Amira Sayed Hanafy
Amira Sayed Hanafy
Associate Professor of Pharmaceutics at Faculty of Pharmacy, Pharos University
Verified email at pua.edu.eg
Title
Cited by
Cited by
Year
Nanotechnology-based drug delivery systems for Alzheimer's disease management: Technical, industrial, and clinical challenges
MM Wen, NS El-Salamouni, WM El-Refaie, HA Hazzah, MM Ali, G Tosi, ...
Journal of Controlled Release, 2016
1052016
Complexation as an approach to entrap cationic drugs into cationic nanoparticles administered intranasally for Alzheimer's disease management: preparation and detection in rat …
AS Hanafy, RM Farid, SS ElGamal
Drug development and industrial pharmacy 41 (12), 2055-2068, 2015
652015
Pharmacological, toxicological and neuronal localization assessment of galantamine/chitosan complex nanoparticles in rats: future potential contribution in Alzheimer’s disease …
AS Hanafy, RM Farid, MW Helmy, SS ElGamal
Drug delivery 23 (8), 3111-3122, 2016
572016
Micro-and nanotechnology approaches to improve Parkinson's disease therapy
PV Torres-Ortega, L Saludas, AS Hanafy, E Garbayo, MJ Blanco-Prieto
Journal of Controlled Release 295, 201-213, 2019
362019
Pulsatile core-in-cup valsartan tablet formulations: in vitro evaluation
MS Sokar, AS Hanafy, AH El-Kamel, SS El-Gamal
asian journal of pharmaceutical sciences 8 (4), 234-243, 2013
252013
Novel treatment strategies for brain tumors and metastases
SE El-Habashy, AM Nazief, CE Adkins, MM Wen, AH El-Kamel, ...
Pharmaceutical patent analyst 3 (3), 279-296, 2014
242014
Design of chronomodulated drug delivery system of valsartan: in vitro characterization
M Sokar, A Hanafy, A Elkamel, S El-Gamal
Indian journal of pharmaceutical sciences 77 (4), 470, 2015
92015
Thermoresponsive Hyalomer intra-articular hydrogels improve monoiodoacetate-induced osteoarthritis in rats
AS Hanafy, SO El-Ganainy
International journal of pharmaceutics 573, 118859, 2020
82020
CRISPR/Cas9 delivery potentials in Alzheimer’s disease management: a mini review
AS Hanafy, S Schoch, A Lamprecht
Pharmaceutics 12 (9), 801, 2020
52020
Galantamine transdermal patch shows higher tolerability over oral galantamine in rheumatoid arthritis rat model
LS Kandil, AS Hanafy, SA Abdelhady
Drug development and industrial pharmacy 46 (6), 996-1004, 2020
32020
Hyaluronic-benzydamine oromucosal films outperform conventional mouth rinse in ulcer healing
NS El-Salamouni, AS Hanafy
Journal of Drug Delivery Science and Technology 65, 102690, 2021
12021
Blood-brain barrier models: rationale for selection
AS Hanafy, D Dietrich, G Fricker, A Lamprecht
Advanced Drug Delivery Reviews, 113859, 2021
2021
Intranasal galantamine/chitosan complex nanoparticles elicit neuroprotection potentials in rat brains via antioxidant effect
LS Kandil, AS Hanafy, RM Farid, S Elgammal
Drug Development and Industrial Pharmacy, 1-17, 2021
2021
Galantamine nanoparticles outperform oral galantamine in an Alzheimer’s rat model: pharmacokinetics and pharmacodynamics
SO El-Ganainy, MA Gowayed, M Agami, P Mohamed, M Belal, RM Farid, ...
Nanomedicine 16 (15), 1281-1296, 2021
2021
Nanobiotechnology in Parkinson’s Disease
PV Torres-Ortega, I Martínez-Valbuena, G Martí-Andrés, AS Hanafy, ...
Nanobiotechnology in Neurodegenerative Diseases, 177-208, 2019
2019
Formulation And Evaluation Of Valsartan Pulsatile Drug Delivery Systems
AS Hanafy
The system can't perform the operation now. Try again later.
Articles 1–16